Prime editing optimized RTT permits the correction of the c.8713C>T mutation in DMD gene
Duchenne muscular dystrophy is a severe debilitating genetic disease caused by different mutations in the DMD gene leading to the absence of dystrophin protein under the sarcolemma. We used CRISPR-Cas9 prime editing technology for correction of the c.8713C>T mutation in the DMD gene and tested di...
Saved in:
Main Authors: | Cedric Happi Mbakam (Author), Joel Rousseau (Author), Yaoyao Lu (Author), Anne Bigot (Author), Kamel Mamchaoui (Author), Vincent Mouly (Author), Jacques P. Tremblay (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System
by: Annalisa Lattanzi, et al.
Published: (2017) -
Emerging Perspectives on Prime Editor Delivery to the Brain
by: Eli BenDavid, et al.
Published: (2024) -
Efficient Restoration of the Dystrophin Gene Reading Frame and Protein Structure in DMD Myoblasts Using the CinDel Method
by: Jean-Paul, et al.
Published: (2016) -
Long-term maintenance of dystrophin expression and resistance to injury of skeletal muscle in gene edited DMD mice
by: Dileep R. Karri, et al.
Published: (2022) -
Duchenne muscular dystrophy (DMD) cardiomyocyte-secreted exosomes promote the pathogenesis of DMD-associated cardiomyopathy
by: Melanie Gartz, et al.
Published: (2020)